S&P 500

5.277,51

0,80%

Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Synergy Pharmaceuticals, Inc. (MM) (SGYPD)
Synergy Pharmaceuticals, Inc. (MM) (SGYPD) Notícias

SGYPD

Synergy Pharmaceuticals, Inc. (MM) (SGYPD)

Synergy Pharmaceuticals, Inc. (MM)

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:SGYPD

1

Data	Hora	Fonte	Título	Código	Companhia
01/03/2019	21:13	Dow Jones News	Synergy Pharmaceuticals Is Approved to Sell Assets to Bausch Health	NASDAQ:SGYPD	Synergy Pharmaceuticals, Inc. (MM)
26/02/2019	21:07	Dow Jones News	Bausch Health to Acquire Certain Assets of Synergy Pharmaceuticals Inc.	NASDAQ:SGYPD	Synergy Pharmaceuticals, Inc. (MM)
17/12/2018	18:43	Dow Jones News	Synergy Pharmaceuticals Up 55% on Trulance Progress in Canada	NASDAQ:SGYPD	Synergy Pharmaceuticals, Inc. (MM)
12/12/2018	14:10	Dow Jones News	Former Pharma Highflier Appreciates Bathroom Humor -- Overheard	NASDAQ:SGYPD	Synergy Pharmaceuticals, Inc. (MM)
12/12/2018	11:18	Dow Jones News	Bausch Health to Buy Synergy Pharmaceuticals Out of Bankruptcy for $200 Million--Update	NASDAQ:SGYPD	Synergy Pharmaceuticals, Inc. (MM)
12/12/2018	10:14	Dow Jones News	Bausch Health Agrees to Buy Synergy Pharmaceuticals for $200 Million	NASDAQ:SGYPD	Synergy Pharmaceuticals, Inc. (MM)
03/01/2012	19:44	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:SGYPD	Synergy Pharmaceuticals, Inc. (MM)
27/12/2011	19:05	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:SGYPD	Synergy Pharmaceuticals, Inc. (MM)
22/12/2011	09:01	Edgar (US Regulatory)	Notice of Effectiveness (EFFECT)	NASDAQ:SGYPD	Synergy Pharmaceuticals, Inc. (MM)
21/12/2011	15:18	Edgar (US Regulatory)	Prospectus filed pursuant to Rule 424(b)(3) (424B3)	NASDAQ:SGYPD	Synergy Pharmaceuticals, Inc. (MM)
19/12/2011	20:04	Edgar (US Regulatory)	Securities Registration Statement (simplified form) (S-3/A)	NASDAQ:SGYPD	Synergy Pharmaceuticals, Inc. (MM)
13/12/2011	19:41	Business Wire	Synergy Pharmaceuticals Announces Full Exercise of Over-Allotment Option by Aegis Capital Corp.	NASDAQ:SGYPD	Synergy Pharmaceuticals, Inc. (MM)
13/12/2011	11:00	PR Newswire (US)	Synergy Pharmaceuticals, Inc. Files Suit Against Ironwood Pharmaceuticals, Inc. and its Chief Scientific Officer and Senior V...	NASDAQ:SGYPD	Synergy Pharmaceuticals, Inc. (MM)
13/12/2011	06:00	Business Wire	Synergy Pharmaceuticals, Inc. Files Suit Against Ironwood Pharmaceuticals, Inc. & its Chief Scientific Officer & Senior VP of...	NASDAQ:SGYPD	Synergy Pharmaceuticals, Inc. (MM)
06/12/2011	20:00	Business Wire	Synergy Pharmaceuticals Announces Closing of Public Offering of 1,875,000 Units	NASDAQ:SGYPD	Synergy Pharmaceuticals, Inc. (MM)
01/12/2011	20:14	Edgar (US Regulatory)	Prospectus filed pursuant to Rule 424(b)(2) (424B2)	NASDAQ:SGYPD	Synergy Pharmaceuticals, Inc. (MM)
01/12/2011	11:00	Business Wire	Synergy Pharmaceuticals Inc. Announces Pricing of Public Offering of 1,875,000 Units, Listing on NASDAQ & Effectiveness of Re...	NASDAQ:SGYPD	Synergy Pharmaceuticals, Inc. (MM)